Veracyte (VCYT) Asset Writedowns and Impairment (2012 - 2025)

Veracyte (VCYT) has 10 years of Asset Writedowns and Impairment data on file, last reported at -$5000.0 in Q4 2025.

• Quarterly Asset Writedowns and Impairment fell 100.18% year-over-year to -$5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.5 million (up 508.52% YoY) and the FY2025 annual result came in at $20.5 million, up 508.67% from the prior year.
• Asset Writedowns and Impairment slipped to -$5000.0 in Q4 2025 per VCYT's latest filing, from $20.5 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $34.9 million in Q3 2023, with the low at -$5000.0 in Q4 2025.
• Average Asset Writedowns and Impairment over 4 years is $10.6 million, with a median of $2.8 million recorded in 2024.
• Year-over-year, Asset Writedowns and Impairment slumped 69.57% in 2024 and slumped 100.18% in 2025.
• Veracyte's Asset Writedowns and Impairment stood at $3.3 million in 2022, then soared by 865.61% to $32.0 million in 2023, then slumped by 91.4% to $2.8 million in 2024, then tumbled by 100.18% to -$5000.0 in 2025.
• Business Quant data shows VCYT's Asset Writedowns and Impairment at -$5000.0 in Q4 2025, $20.5 million in Q2 2025, and $2.8 million in Q4 2024.